Histopathological features of familial amyloidotic polyneuropathy: a report of a case with postmortem examination
- Author:
- No author available
- Journal Title:
- Chinese Journal of Neuromedicine
- Issue:
- 9
- DOI:
- 10.3760/cma.j.issn.1671-8925.2012.09.019
- Key Word:
- 周围神经病;淀粉样变性;家族性;转甲状腺素蛋白;尸检;Peripheral Neuropathy;Amyloidosis;Familial;Transthyretin;Autopsy
Abstract： Objective To analyze and conclude the clinlcal and histopathological features of a proband with familial amyloidotic polyneuropathy (FAP) by postmortem examination and gene sequencing of DNA from peripheral blood to provide reference in further understanding the disease.Methods Morphological study was constructed by hematoxylin and eosin (HE) staining, congo red staining and birefringence with thioflavin under microscope, and by immunolabeling with polyclonal rabbit antibodies to transthyretin under polarized microscope. Results Genetic findings of transthyretin (TTR) gene revealed a T to C transition in codon 30 causing the mutation TTR Ala30; this proband belonged TTR Val30Met FAP type.Autopsy showed heavy amyloid deposition in the peripheral nerves,liver,testes,thyroid,pancreas and muscles.The spleen showed only slight deposition,and none was observed in the central nervous system. Conclusion Distinction is noted on pathological changes of Chinese FAP patient with TTR Val30Ala and other FAP patient with typical TTR Val30Met.
- [1]B.-O. OLOFSSON,K. GRANKVIST,T. OLSSON,etc.Assessment of hypothalamic-pituitary function in patients with familial amyloidotic polyneuropathy[J].1991,229(1).
- [2]Sekijima Y,Tokuda T,Yanagisawa N,etc.No association between apolipoprotein E epsilon4 allele and the age of onset in type I familial amyloid polyneuropathy.[J].1996,204(3).
- [3]Dardiotis E,Koutsou P,Zamba Papanicolaou E.Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.[J].2009,284(1/2).
- [4]Kiyoshi Takahashi,Naorni Sakashita,Yukio Ando,etc.Late onset type I familial amyloidotic polyneuropathy: Presentation of three autopsy cases in comparison with 19 autopsy cases of the ordinary type[J].1997,47(6).
- [5]M B, Pepys,J, Herbert,W L, Hutchinson,etc.Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.[J].2002,417(6886).
- [6]Son H,Lee DH,Lee KW.Clusterin regulates transthyretin amyloidosis.[J].2009,388(2).
- [7]Benson MD,Kincaid JC.The molecular biology and clinical features of amyloid neuropathy.[J].2007,36(4).
- [8]Takahashi K,Kinjo M,Ando Y,etc.Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report.[J].2000,436(4).
- [9]Iida H,Kobayashi F,Shindo K,etc.Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.[J].2009,276(1).
- [10]B.-O. OLOFSSON,K. GRANKVIST,K. BOMAN,etc.Assessment of thyroid and adrenal function in patients with familial amyloidotic polyneuropathy[J].1989,225(5).
- [11]Tennent GA,Lovat LB,Pepys MB.Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.[J].1995,92(10).
- [12]Plante Bordeneuve V,Said G.Familial amyloid polyneuropathy.[J].2011,10(12).
- [13]Kiyoshi Takahashi,Shigehiro Yi,Yoshihiro Kimura,etc.Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: A clinicopathologic, histochemical, immunohistochemical, and ultrastructural study[J].1991,22(6).